Dania Therapeutics ApS — Credit Rating and Financial Key Figures

CVR number: 42523925
Store Kongensgade 77, 1264 København K

Income statement (kDKK)

2022
2023
2024
Fiscal period length121212
Net sales
External services-12 859.00-9 191.44-8 836.65
Gross profit-12 859.00-9 191.44-8 836.65
Employee benefit expenses-1 240.00-1 480.00
EBIT-12 859.00-10 431.44-10 316.65
Other financial income300.0041.93444.51
Other financial expenses-2.00- 332.82-1 581.61
Pre-tax profit-12 561.00-10 722.33-11 453.75
Income taxes2 820.002 000.371 896.90
Net earnings-9 741.00-8 721.96-9 556.86

Assets (kDKK)

2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables173.95126.91
Current deferred tax assets2 820.002 000.371 896.90
Short term receivables total2 820.002 174.322 023.81
Cash and bank deposits170.0012 888.825 112.50
Cash and cash equivalents170.0012 888.825 112.50
Balance sheet total (assets)2 990.0015 063.147 136.31

Equity and liabilities (kDKK)

2022
2023
2024
Share capital55.0059.3059.71
Share premium account12 512.0017 177.05
Retained earnings-9 741.27- 876.19
Profit of the financial year-9 741.00-8 721.96-9 556.86
Shareholders equity total2 826.00-1 226.88-10 373.33
Non-current loans from credit institutions15 610.7116 754.30
Non-current owed to participating26.00
Non-current deferred tax liabilities74.00
Non-current liabilities total100.0015 610.7116 754.30
Current trade creditors35.00220.11253.62
Other non-interest bearing current liabilities29.00459.20501.72
Current liabilities total64.00679.31755.34
Balance sheet total (liabilities)2 990.0015 063.147 136.31
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.